The TGA says 8 out of 12 medical scribe products being used by doctors in Australia may be affecting diagnostic and clinical decisions. These products must now go through the registration process as medical devices. Despite data showing younger people are drinking less, rates of hospitalisation for alcohol related liver diseases in that cohort are still higher than they were before the pandemic. A comparison of twenty-one different anti-depressant medications showed they were more effective than placebo in adults with major depressive disorder. But some medications were found to be slightly more beneficial than others. How does that affect prescribing? References TGA - Digital Scribe review outcomes (https://www.tga.gov.au/resources/publication/corporate-reports/digital-scribe-review-outcomes) Alcohol-related liver disease epidemiology in Victoria (https://fare.org.au/alcohol-related-liver-disease-epidemiology-in-victoria/) ABC News: Severe alcohol-related liver disease common in young
Using NHS data, researchers compared full and partial knee replacements done with and without robotics to see if the outcomes were better for patients in the period following the procedures. A new study compares a less invasive method, called intrauterine insemination (IUI) as a first line treatment, against IVF alone. A white paper from the International Menopause Society seeks to clarify the understanding and impacts of musculoskeletal pain, migraine and pelvic pain during mid-life. References Daily weight-loss tablet Wegovy cleared by TGA for use in Australia (https://www.abc.net.au/news/2026-11-03/weight-loss-tablet-cleared-for-use-in-australia/107343340) New Medicare health check for 3-year-old children (https://www.health.gov.au/ministers/the-hon-mark-butler-mp/media/new-medicare-health-check-for-3-year-old-children?language=en) Australian Journal of General Practice: A guide to the 3-year-old health check for general practice (https://www1.racgp.org.au/ajgp/2026/september/a-guid